Manifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021

dc.contributorZuluaga De León, Iván
dc.contributorNavarro Baene, Gina
dc.creatorCastellón De La Rosa, Evis Adriana
dc.creatorJiménez Arcia, Luisa Fernanda
dc.date.accessioned2022-12-05T20:27:53Z
dc.date.available2022-12-05T20:27:53Z
dc.date.created2022-12-05T20:27:53Z
dc.identifierhttps://hdl.handle.net/10901/23839
dc.description.abstractOBJETIVO GENERAL Determinar las manifestaciones clínicas posagudas y nivel de calidad de vida a 6 meses en pacientes atendidos por COVID-19 en el Hospital General de Barranquilla, durante el periodo de enero a julio de 2021. METODOLOGÍA Estudio descriptivo, longitudinal, prospectivo. Los datos fueron obtenidos del Hospital General de Barranquilla y el seguimiento a 6 meses se realiza— por vía telefónica mediante encuesta de síntomas y escala SF12. El análisis se hizo mediante el programa SPSS en su versión 15. Se emplearon medidas descriptivas para el análisis univariado: porcentaje y promedio y desviación estándar. Para el análisis bivariado se emplea— prueba t.Ê RESULTADOS De 16 manifestaciones clínicas postagudas descritas en la literatura, la disnea y la fatiga, fueron las más frecuentes, con 42,2% y 41,3%, respectivamente, el resto de las manifestaciones estuvieron entre 13,9% y 28,3%. El resultado de los componentes de salud física y salud mental, según el SF-12, muestran que, en ninguno de los casos el promedio llega a 50 puntos, siendo más bajo para salud física (Prom: 38,1 +/-5,5). ??Al comparar los promedios de salud física y emocional según las variables sociodemográficas, se encontraron diferencias significativas (p<0,05) para el sexo (mayor puntaje en hombres) en salud física y para el estrato (mayor puntaje en el estrato dos) en salud mental. Al relacionar los promedios de las dimensiones salud física y salud mental según cada una de las manifestaciones clínicas postagudas, no se encontraron diferencias significativas en ninguno de los casos, con excepción—n del dolor torácico en la primera dimensión. CONCLUSIONES La dificultad respiratoria y la fatiga fueron las manifestaciones más frecuentes. Los puntajes del SF-12 tanto para el componente de salud física como para el de salud mental fueron relativamente bajos en la mayoría de los participantes, por lo que solamente se encontraron diferencias significativas al cruzar salud física con sexo y salud mental con estrato socioeconómico, para el caso de las variables sociodemográficas. Para las manifestaciones clínicas postagudas no hubo diferencias significativas entre los que las padecían y los que no.
dc.relationWho.int (Internet). Estados Unidos: Whoint; 2000 [actualizado 06 de noviembre 2020; citado 1 de noviembre de 2020. Tomado de: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public Fecha de acceso: febrero de 2021
dc.relationCoronavirus.jhu.edu. Estados Unidos: coronavirus.jhu.edu; 2020. Tomado de: https://coronavirus.jhu.edu/map.html Fecha de acceso: febrero de 2021
dc.relationGreenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of postacute COVID-19 in primary care. BMJ. 2020;370:m3026
dc.relationDel Rio C, Collins L, Malani P. Long-term health consequences of COVID19. Jama, 2020; 324(17): 1723-1724
dc.relationHuang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, Zhou X et al. Impact of Coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020; 21:163
dc.relationCarfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID -19. JAMA. 2020; 324(6):603-605
dc.relationBao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. The Lancet, 2020; 395(10224): e37-e38
dc.relationXu Z, Li S, Tian S, Li H, Kong L. Full spectrum of COVID-19 severity still being depicted. Lancet, 2020; 395(10228): 947
dc.relationJack A. Why the panic? South Korea’s MERS response questioned. Bmj, 2015; 350(1): h3403
dc.relationAbdel-Moneim A. Middle East respiratory syndrome coronavirus: Is it worth a world panic? World journal of virology, 2015; 4(3): 185-187
dc.relationBrooks S, Webster R, Smith L, Woodland L, Wessely S, Greenberg N, Rubin G. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet, 2020; 395(10227): P912-P920
dc.relationArab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-Related Quality of Life and its Associated Factors in. COVID-19 Patients. Osong Public Health Res Perspect 2020;11(5):296-302
dc.relationPiedra J, Cuellar C, Machado V. Instrumentos evaluadores de secuelas en pacientes postinfección a COVID-19. Su utilidad en rehabilitación. Revista Cubana de Medicina Física y Rehabilitación, 2020; 12(3): 1-22
dc.relationValdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay, 2020; 10(2): 78-88
dc.relationMaley J, Brewster I, Mayoral I, Siruckova R, Adams S, McGraw K, Mikkelsen M. Resilience in survivors of critical illness in the context of the survivors’ experience and recovery. Ann Am Thorac Soc. 2016;13(8):1351-1360
dc.relationCarfì A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA, 2020;324(6):603-605
dc.relationTenforde M, Kim S, Lindsell C y cols.; IVY Network Investigators; CDC COVID19 Response Team; IVY Network Investigators. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network: United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998
dc.relationCaliari D, Campos K, Dos Santos P, Louro S, Curty T, Mendanha T, Dos Reis E. Associação entre las características sociodemográficas y síntomas da COVID-19 em pacientes residentes do Espírito Santo, Brasil: Association between the sociodemographic characteristics and COVID-19 symptoms in patients resident in Espírito Santo state, Brazil. Health and Biosciences, 2020; 1(2): 32-51
dc.relationInstituto Nacional de Salud. Coronavirus. Tomado de: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx Fecha de acceso: febrero de 2021
dc.relationRothan H, Byrareddy S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity, 2020; 109(1): 102433
dc.relationPuntmann V, Carerj M, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3557
dc.relationRajpal S, Tong M, Borchers J, Zareba K, Obarski T, Simonetti O, Daniels C. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA cardiology, 2021; 6(1): 116-118
dc.relationZhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, Luo H. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine, 2020; 25(1): 100463
dc.relationZubair A, McAlpine L, Gardin T, Farhadian S, Kuruvilla D, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018-1027
dc.relationGalea S, Merchant R, Lurie N. The mental health consequences of COVID19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020;180(6):817-818
dc.relationWare J, Kosinski M, Keller S. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical care, 1996; 34(1): 220-233
dc.relationCleaton N, Raizada S, Barkham N, Venkatachalam S, Sheeran T, Adizie T, Bateman J. COVID-19 prevalence and the impact on quality of life from stringent social distancing in a single large UK rheumatology centre. Annals of the Rheumatic Diseases, 2021; 80(6): e93-e93
dc.relationLiu C, Stevens C, Conrad R, Hahm H. Evidence for elevated psychiatric distress, poor sleep, and quality of life concerns during the COVID-19 pandemic among US young adults with suspected and reported psychiatric diagnoses. Psychiatry research, 2020; 292(1): 113345
dc.relationDi Stefano V, Battaglia G, Giustino V, Gagliardo A, D’Aleo M, Giannini O, Brighina F. Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine. Journal of neurology, 2020; 1(1): 1-7
dc.relationWalline J. COVID -19- Quality of Life After Infection. Clinical Trials. gov: NCT04377464. Chinese University of Hong Kong. 2020. disponible en https://clinicaltrials.gov/ct2/show/NCT04377464#contacts
dc.relationSaavedra C, Buitrago A, Jiménez A, Mejía A, Narváez A, Rojas A, et al. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud. Infectio. 2020; 24 (3):1-153
dc.relationMaréchal M, Morand P, Epaulard O, Némoz B. COVID-19 in clinical practice: a narrative synthesis. Med Mal Infect, 2020; 50(20): 30710-1
dc.relationGordon D, Jang G, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARSCoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020; 583
dc.relationHou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, et al. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020;2
dc.relationHoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181:271-280.e8
dc.relationChan J, Yuan S, Kok K, Wang K, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. Lancet. 2020; 395: 514–23
dc.relationLei J, Li J, Li X, Qi X. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 2020; 295(1): 18-18
dc.relationLu H. Drug treatment options for the 2019-new coronavirus (2019- nCoV). Bioscience trends, 2020;14(1): 69-71
dc.relationHuang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020; 395(10223): 497-506
dc.relationLuo W, Yu H, Gou J, Li X, Sun Y, Li J, Liu L. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints, 2020: 2020020407
dc.relationBonaventura A, Vecchié A, Dagna L, Martinod K, Dixon D, Van Tassell B, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nature Reviews Immunology, 2021; 21(5): 319- 329
dc.relationLi Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Xing X. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 2020; 382(1):1199-1207
dc.relationWang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol, 2020; 92(4): 441– 447
dc.relationCarlos W, Dela Cruz C, Cao B, Pasnick S, Jamil S. Novel wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med, 2020; 201(4): 7–8
dc.relationAssiri A, Al-Tawfiq J, Al-Rabeeah A, Al-Rabiah F, Al-Hajjar S, Al-Barrak A, Makhdoom H. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet infectious diseases, 2013; 13(9): 752- 761
dc.relationPhan L, Nguyen T, Luong Q, Nguyen T, Nguyen H, Le H, Pham Q. Importation, and human-to-human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine, 2020; 382(9), 872-874
dc.relationLi X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Zhang C. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology, 2020; 146(1): 110-118
dc.relationGuan W, Ni Z, Hu Y, Liang W, Ou C, He J, Du B. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 2020; 382(18): 1708-1720
dc.relationHe L, Ding Y, Zhang Q, Che X, He Y, Shen H, Deng Y. Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 2006; 210(3): 288-297
dc.relationSheng W, Chiang B, Chang S, Ho H, Wang J, Chen Y, Yang P. Clinical manifestations, and inflammatory cytokine responses in patients with severe acute respiratory syndrome. Journal of the Formosan Medical Association= Taiwan yi zhi, 2005; 104(10): 715-723
dc.relationZhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, Gao Y. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 2020; 75(7): 1730-1741
dc.relationWu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, Song J. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine, 2020; 180(7): 934-943
dc.relationCrackower M, Sarao R, Oudit G, Yagil C, Kozieradzki I, Scanga S, Scholey J. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature, 2002; 417(6891): 822-828
dc.relationLineamientos para el uso de pruebas diagnósticas para SARS-CoV-2 (COVID-19) en Colombia. Ministerio de salud y protección social. Marzo 2022
dc.relationCorman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan 1;25(3)
dc.relationU.S. Department of Health & Human Services (2020) Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus. 24 Jan 2020. En: https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-fordetectioninstructions.pdf. 2014
dc.relationLiu R, Han H, Liu F, Lv Z, Wu K, Liu Y, Zhu C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clinica Chimica Acta, 2020; 505(1): 172-175
dc.relationAi T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Xia L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology, 2020; 200642
dc.relationThoracic S. Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection (Trial version). Zhonghua jie he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and respiratory diseases, 2020;43(3): 199
dc.relationTrujillo C. Resumen: Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud. Infectio, 2020; 24(3): 1- 175
dc.relationVillarroel P, Silva J, Atenas C, Pavez P. Evaluación del cuestionario SF-12: verificación de la utilidad de la escala salud mental. Rev Med Chile 2014; 142: 1275-1283
dc.relationUrzúa A, Caqueo-Urízar A. Calidad de vida: Una revisión teórica del concepto. Ter Psicol 2012; 30 (1): 61-72
dc.relationRebollo P. Utilización del «grupo SF» de los cuestionarios de calidad de vida (SF-36, SF-12 y SF-6D) en el marco de ensayos clínicos y en la práctica clínica habitual. Med Clin (Barc) 2008; 130 (19): 740-1
dc.relationWölfel R, Corman V, Guggemos W, Seilmaier M, Zange S, Müller M, Hoelscher M. Virological assessment of hospitalized patients with COVID2019. Nature, 2020; 581(7809): 465-469
dc.relationZhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Qian S. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical Infectious Diseases, 2020; 71(16): 2027-2034
dc.relationTo K, Tsang O, Leung W, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565-574
dc.relationWu L, Wang N, Chang Y, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562-1564
dc.relationPayne D, Iblan I, Rha B, et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016;22(10):1824-1826
dc.relationXing Y, Mo P, Xiao Y, Zhao O, Zhang Y, Wang F. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. euro Surveill. 2020;25(10). doi:10.2807/1560-7917.ES.2020.25.10.2000191
dc.relationXiao A, Tong Y, Zhang S. False‐negative of RT‐PCR, and prolonged nucleic acid conversion in COVID‐19: rather than recurrence. Journal of medical virology, 2020; 92(10): 1755-1766
dc.relationYoung BE, Ong S, Kalimuddin S, et al; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients with SARS-CoV-2 in Singapore. JAMA. 2020;232(15):1488-1494
dc.relationKirkcaldy R, King B, Brooks J. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions. Jama, 2020; 323(22): 2245-2246
dc.relationXiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection, 2020; 27(1): 89-95
dc.relationNalbandian A, Sehgal K, Gupta A, Madhavan M, McGroder C, Stevens J, Wan y cols. Post-acute COVID-19 syndrome. Nature medicine, 2021; 1-15
dc.relationLogue J, Franko N, McCulloch D, McDonald D, Magedson A, Wolf C, Chu H. Sequelae in adults at 6 months after COVID-19 infection. JAMA network open, 2021; 4(2): e210830-e210830
dc.relationHalpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. Journal of medical virology, 2021; 93(2): 1013-1022
dc.relationGarrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Nguyen Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection, 2020; 81(6): e4-e6
dc.relationChopra V, Flanders S, O'Malley M, Malani A, Prescott H. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Annals of Internal Medicine, 2020:1-3
dc.relationMartin-Villares C, Molina-Ramirez C, Bartolome-Benito M, Bernal-Sprekelsen M. Outcome of 1890 tracheostomies for critical COVID-19 patients: a national cohort study in Spain. European Archives of Oto-Rhino-Laryngology, 2021; 278(5): 1605-1612
dc.relationHosey M, Needham D. Survivorship after COVID-19 ICU stay. Nature reviews Disease primers, 2020; 6(1): 1-2
dc.relationInoue S, Hatakeyama J, Kondo Y, Hifumi T, Sakuramoto H, Kawasaki T, Nishida O. Post‐intensive care syndrome: its pathophysiology, prevention, and future directions. Acute medicine & surgery, 2019; 6(3): 233-246
dc.relationHerridge M, Tansey C, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Cheung A. Functional disability 5 years after acute respiratory distress syndrome. New England Journal of Medicine, 2011; 364(14): 1293-1304
dc.relationHuppert L, Matthay M, Ware L. Pathogenesis of acute respiratory distress syndrome. In Seminars in respiratory and critical care medicine, 2019; 40(1): 31
dc.relationSchaller T, Hirschbühl K, Burkhardt K, Braun G, Trepel M, Märkl B, Claus R. Postmortem examination of patients with COVID-19. Jama, 2020; 323(24): 2518-2520
dc.relationDe Michele S, Sun Y, Yilmaz M, Katsyv I, Salvatore M, Dzierba A, Saqi A. Forty Postmortem Examinations in COVID-19 Patients: Two Distinct Pathologic Phenotypes and Correlation with Clinical and Radiologic Findings. American journal of clinical pathology, 2020; 154(6): 748-760
dc.relationMoodley Y, Scaffidi A, Misso N, Keerthisingam C, McAnulty R, Laurent G, Knight D. Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. The American journal of pathology, 2003; 163(1): 345-354
dc.relationBharat A, Querrey M, Markov N, Kim S, Kurihara C, Garza-Castillon R, Budinger G. Lung transplantation for patients with severe COVID-19. Science translational medicine, 2020; 12(574): eabe4282
dc.relationLang M, Som A, Mendoza D, Flores E, Reid N, Carey D, Little B. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. The Lancet Infectious Diseases, 2020; 20(12): 1365-1366
dc.relationPatell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird W, Zwicker J. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood, The Journal of the American Society of Hematology, 2020; 136(11): 1342- 1346
dc.relationPavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri F. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. Journal of thrombosis and thrombolysis, 2020; 50(1): 281-286
dc.relationBikdeli, B., Madhavan, M. V., Gupta, A., Jimenez, D., Burton, J. R., Der Nigoghossian, C., ... & Group, T. C. (2020). Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thrombosis and haemostasis, 202; 120(7): 1004-1024
dc.relationCarvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, BourbaoTournois C, Laribi S, Bernard L. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infection, 2021; 27(2): 258-263
dc.relationHuang C, Huang L, Wang Y, Li X, Ren L, Gu X, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 2021; 397(10270): 220-232
dc.relationLindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, Westermann D. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA cardiology, 2020; 5(11): 1281- 1285
dc.relationSiripanthong, B., Nazarian, S., Muser, D., Deo, R., Santangeli, P., Khanji, M. Y., ... & Chahal, C. A. A. (2020). Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart rhythm, 17(9), 1463-1471
dc.relationWu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, Chen H. Altered lipid metabolism in recovered SARS patients twelve years after infection. Scientific reports, 2017; 7(1): 1-12
dc.relationLiu P, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation, 2020; 142(1): 68-78
dc.relationNordvig A, Fong K, Willey J, Thakur K, Boehme A, Vargas W, Elkind M. Potential neurologic manifestations of COVID-19. Neurology: Clinical Practice, 2021; 11(2): e135-e146
dc.relationBolay H, Gül A, Baykan B. COVID‐19 is a Real Headache! Headache: The Journal of Head and Face Pain, 2020; 60(7): 1415-1421
dc.relationPozo-Rosich, P. Headache & COVID-19: a short-term challenge with long-term insights. In Proc. AHSAM 2020 Virtual Annual Scientific Meeting (Infomedica, 2020); https://www.ahshighlights.com/ summariespodcasts/article/ headache-COVID-19-a-short- term-challenge-with- longterm-insights
dc.relationKaseda E, Levine A. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. The Clinical Neuropsychologist, 2020; 34(7-8): 1498-1514
dc.relationMazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I. COVID19 BioB Outpatient Clinic Study group. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain, behavior, and immunity, 2020; 89(1): 594-600
dc.relationSouth K, McCulloch L, McColl B, Elkind M, Allan S, Smith C. Preceding infection, and risk of stroke: an old concept revived by the COVID-19 pandemic. International Journal of Stroke, 2020; 15(7): 722-732
dc.relationReichard R, Kashani K, Boire N, Constantopoulos E, Guo Y, Lucchinetti C. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta neuropathologica, 2020;140(1): 1-6
dc.relationAiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino C, Accardi G. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Frontiers in immunology, 2019; 10(1): 2247
dc.relationStevens J, King K, Robbins-Juarez S, Khairallah P, Toma K, Alvarado Verduzco H, Mohan S. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PloS one, 2020; 15(12): e0244131
dc.relationWilbers T, Koning M. Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery, and filter lifetime. Journal of Critical Care, 2020; 60(1): 103-105
dc.relationJhaveri K, Meir L, Chang B, Parikh R, Wanchoo R, Barilla-LaBarca M, Hajizadeh N. Thrombotic microangiopathy in a patient with COVID-19. Kidney international, 2020; 98(2): 509-512
dc.relationSuwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID‐19: Causality or coincidence? A report of three cases. Journal of medical virology, 2021; 93(2): 1150-1153
dc.relationMateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID19. Journal of Endocrinological Investigation, 2020; 43(10): 1527-1528
dc.relationSalvio G, Gianfelice C, Firmani F, Lunetti S, Balercia G, Giacchetti G. Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications. Clinical Reviews in Bone and Mineral Metabolism, 2020; 1-7
dc.relationArnold D, Hamilton F, Milne A, Morley A, Viner J, Attwood M, Barratt S. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax, 2021; 76(4): 399-401
dc.relationXu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, Gong S. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nature medicine, 2020; 26(4): 502-505
dc.relationZeppa S, Agostini D, Piccoli G, Stocchi V, Sestili P. Gut Microbiota Status in COVID-19: An Unrecognized Player? Frontiers in cellular and infection microbiology; 2020, 10:1-10
dc.relationBradley K, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, Wack A. Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell reports, 2019; 28(1): 245-256
dc.relationMiquel S, Martin R, Rossi O, Bermudez-Humaran L, Chatel J, Sokol H, Langella P. Faecalibacterium prausnitzii and human intestinal health. Current opinion in microbiology, 2013; 16(3): 255-261
dc.relationFreeman E, McMahon D, Lipoff J, Rosenbach M, Kovarik C, Desai S, Fox L. The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries. Journal of the American Academy of Dermatology, 2020; 83(4): 1118-1129
dc.relationMirza F, Malik A, Omer S, Sethi A. Dermatologic manifestations of COVID‐19: a comprehensive systematic review. International journal of dermatology, 2021; 60(4): 418-450
dc.relationGenovese G, Moltrasio C, Berti E, Marzano A. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology, 2020; 237(1): 1-12
dc.relationVilagut G, Valderas J, Ferrer M, Garin O, López-García E, Alonso J. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Medicina clínica, 2008; 130(19): 726-735
dc.relationGupta A, Madhavan M, Sehgal K, Nair N, Mahajan S, Sehrawat T, Landry D. Extrapulmonary manifestations of COVID-19. Nature medicine, 2020; 26(7): 1017-1032
dc.relationCarfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. Jama, 2020; 324(6): 603-605
dc.relationPettrone K, Burnett E, Link-Gelles R, Haight S, Schrodt C, England L, Killerby M. Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March–April 2020. Emerging infectious diseases, 2021; 27(4): 1164
dc.relationMcElvaney O, McEvoy N, McElvaney O, Carroll T, Murphy M, Dunlea D, McElvaney N. Characterization of the inflammatory response to severe COVID-19 illness. American journal of respiratory and critical care medicine, 2020; 202(6): 812-821
dc.relationSeeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, Merle U. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clinical infectious diseases, 2022; 74(7): 1191-1198
dc.relationLogue J, Franko N, McCulloch D, McDonald D, Magedson A, Wolf C, Chu H. Sequelae in adults at 6 months after COVID-19 infection. JAMA network open, 2021; 4(2): e210830-e210830
dc.relationTalman S, Boonman-de Winter L, De Mol M, Hoefman E, Van Etten R, De Backer I. Pulmonary function and health-related quality of life after COVID19 pneumonia. Respiratory Medicine, 2021; 176(1): 106272
dc.relationVaes A, Goërtz Y, Van Herck M, Machado F, Meys R, Delbressine J, Spruit M. Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ open research, 2021; 7(2): 2345
dc.relationVlake J, Wesselius S, van Genderen M, van Bommel J, Boxma-de Klerk B, Wils E. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study. PloS one, 2021; 16(8): e0255774
dc.relationSudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R, Steves C. Attributes and predictors of long COVID. Nature medicine, 2021; 27(4): 626-631
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCOVID 19
dc.subjectManifestaciones posagudas
dc.subjectCalidad de vida
dc.subjectFactores de riesgo
dc.titleManifestaciones clínicas Posagudas y calidad de vida de pacientes atendidos por Covid-19 en una institución de la red pública de Barranquilla, de enero a julio del 2021


Este ítem pertenece a la siguiente institución